The effect of magnesium supplement on serum fasting glucose and C-reactive protein level in type 2 diabetic patients

Phase 3

Completed

• Conditions: DiabetesType 2No complication; Diabetes; Type 2

• Registration Number: TCTR20210412001
• Lead Sponsor: researcher

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-03-21
• Study Start: 2021-04-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 29

Inclusion Criteria

1. Any gender, age 30-65 years old
2. Diagnosed as Type 2 diabetes at least 6 months before
3. Well controlled blood glucose, no plan to adjusted the medicine during experimental
4. FBS 100-250 mg/dl
5. Good conscious and decision
6. Acceptable to thesis method
7. Acceptable following up

Exclusion Criteria

1. Having diabetic complication
2. CKD
3. Using steroid, antiinflammation medicine, herb , other product lowering blood sugar
4. Using diuretic
5. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fasting blood glucose One month Blood sample

Secondary Outcome Measures

Name	Time	Method
C-reactive protein One months Blood sample